|
BAT2L2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.65600000051813E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.02299999999945E-05 |
| Normal-vs-Stage2 |
6.303700E-03 |
| Normal-vs-Stage3 |
3.42580000001202E-06 |
| Normal-vs-Stage4 |
8.74559999974878E-07 |
| Stage1-vs-Stage2 |
8.192600E-01 |
| Stage1-vs-Stage3 |
2.394800E-01 |
| Stage1-vs-Stage4 |
5.791900E-02 |
| Stage2-vs-Stage3 |
5.641200E-01 |
| Stage2-vs-Stage4 |
2.489600E-01 |
| Stage3-vs-Stage4 |
4.184600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.03079999997414E-07 |
| Normal-vs-AfricanAmerican |
4.977300E-03 |
| Normal-vs-Asian |
2.048800E-04 |
| Caucasian-vs-AfricanAmerican |
8.091200E-01 |
| Caucasian-vs-Asian |
1.157180E-01 |
| AfricanAmerican-vs-Asian |
1.219230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5646799999991E-05 |
| Normal-vs-Female |
2.26379999967996E-07 |
| Male-vs-Female |
1.723200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.081580E-01 |
| Normal-vs-Age(41-60Yrs) |
4.30659999994809E-07 |
| Normal-vs-Age(61-80Yrs) |
3.08140000004897E-06 |
| Normal-vs-Age(81-100Yrs) |
1.254240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.364400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.745000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.238200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.877200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.274400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.320200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.543700E-03 |
| Normal-vs-Grade 2 |
1.44049999994955E-06 |
| Normal-vs-Grade 3 |
2.360500E-04 |
| Normal-vs-Grade 4 |
2.99149999993809E-07 |
| Grade 1-vs-Grade 2 |
1.087970E-01 |
| Grade 1-vs-Grade 3 |
4.312100E-02 |
| Grade 1-vs-Grade 4 |
4.424800E-01 |
| Grade 2-vs-Grade 3 |
2.304200E-01 |
| Grade 2-vs-Grade 4 |
9.933900E-02 |
| Grade 3-vs-Grade 4 |
1.279930E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.04509999952074E-07 |
| Normal-vs-ccB subtype |
4.25750000000447E-05 |
| ccA subtype-vs-ccB subtype |
6.778000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.51139999996042E-06 |
| Normal-vs-N1 |
1.74669999997157E-06 |
| N0-vs-N1 |
3.523900E-02 |
|
|
